RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Free Cash Flow Growth TrendStable
Percentile Rank44
Year-over-Year Change
Year-over-year free cash flow growth rate
Latest
0.00%
↑ 100% vs avg
Percentile
P44
Within normal range
Streak
1 qtr
Consecutive growthStable
Average
-21.05%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -57.24% |
| Q4 2024 | 0.00% |
| Q3 2024 | 48.40% |
| Q2 2024 | 0.00% |
| Q1 2024 | 65.73% |
| Q4 2023 | 0.00% |
| Q3 2023 | 14.83% |
| Q2 2023 | -47.45% |
| Q1 2023 | -196.66% |
| Q4 2022 | 59.96% |
| Q3 2022 | 63.87% |
| Q2 2022 | -301.73% |
| Q1 2022 | 71.96% |
| Q4 2021 | 21.97% |
| Q3 2021 | -0.77% |
| Q2 2021 | -52.98% |
| Q1 2021 | 3.13% |
| Q4 2020 | -26.63% |
| Q3 2020 | 85.09% |
| Q2 2020 | -460.62% |
| Q1 2020 | 13.55% |
| Q4 2019 | -56.68% |
| Q3 2019 | 15.93% |
| Q2 2019 | -40.35% |
| Q1 2019 | 8.05% |
| Q4 2018 | 2.10% |
| Q3 2018 | 0.31% |
| Q2 2018 | 16.07% |
| Q1 2018 | 29.36% |
| Q4 2017 | -21.82% |
| Q3 2017 | -18.32% |
| Q2 2017 | 4.76% |
| Q1 2017 | -0.84% |
| Q4 2016 | -38.69% |
| Q3 2016 | -28.28% |
| Q2 2016 | -14.83% |
| Q1 2016 | 16.90% |
| Q4 2015 | -58.78% |
| Q3 2015 | 38.61% |